Close
RNS Number : 9815G
Seplat Petroleum Development Co PLC
20 March 2020
 

Seplat Petroleum Development Company Plc

("Seplat" or "the Company")

NOTICE OF DECISION BY THE SEPLAT BOARD OF DIRECTORS

 

Lagos, Nigeria - 20th March 2020: In line with Section 1.1 of the Rules Relating to Board Meetings and General Meetings of issuers, there is an obligation on the Issuer to notify the Exchange within twenty-four hours after the relevant Board meeting of the key decisions taken by the Board.

 

It is hereby stated that the Company held its Board meeting on Thursday, 19th March 2020 to review and approve its 2019 Full Year Financial Results for the period ended 31st December 2019.

 

The results were duly considered and approved by the Board and will be filed with the Exchange on Monday, 23rd March 2020. The Board also proposed a final dividend of US$0.05 (United States Five Cents) for its Shareholders which is subject to their approval at the Company's AGM scheduled to hold on 28th May 2020. 

 

- ENDS -

 

Enquiries

Seplat Petroleum Development Company Plc


Roger Brown, CFO

+44 (0) 203 725 6500

Edith Onwuchekwa, Company secretary

+234 (01) 277 0400

 

FTI Consulting


Ben Brewerton / Sara Powell

 

+44 (0) 203 727 1000


seplat@fticonsulting.com

 



Notes to editors

Seplat Petroleum Development Company Plc is a leading indigenous Nigerian oil and gas exploration and production company with a strategic focus on Nigeria, listed on the Main Market of the London Stock Exchange ("LSE") (LSE:SEPL) and Nigerian Stock Exchange ("NSE") (NSE:SEPLAT).

Seplat is pursuing a Nigeria focused growth strategy and is well-positioned to participate in future divestment programmes by the international oil companies, farm-in opportunities and future licensing rounds.  For further information please refer to the company website, http://seplatpetroleum.com/

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMZGZFLGFGGZG